Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	bradykinin catabolic process	IDE ECE1 CTSH	1.27e-05	7	149	3	GO:0010815
GeneOntologyCellularComponent	leading edge membrane	ANK1 VEZT DOCK8 GRIN2A PIP5K1C MTMR6 BMX EGFR USH2A	2.03e-05	210	149	9	GO:0031256
GeneOntologyCellularComponent	cell leading edge	ANK1 VEZT DOCK8 GRIN2A PIP5K1C MTMR6 BMX DST EGFR PTPRM MCF2L USH2A FGD6	6.24e-05	500	149	13	GO:0031252
GeneOntologyCellularComponent	sperm midpiece	AKAP3 CFAP65 FSIP2 PACRG CFAP69	9.35e-05	64	149	5	GO:0097225
GeneOntologyCellularComponent	9+2 motile cilium	AKAP3 DNAH1 CFAP65 FSIP2 PACRG CFAP69 CTSH DNAH11	3.15e-04	238	149	8	GO:0097729
GeneOntologyCellularComponent	stereocilia ankle link	VEZT USH2A	7.43e-04	6	149	2	GO:0002141
GeneOntologyCellularComponent	stereocilia ankle link complex	VEZT USH2A	7.43e-04	6	149	2	GO:0002142
GeneOntologyCellularComponent	stereocilium membrane	VEZT USH2A	7.43e-04	6	149	2	GO:0060171
GeneOntologyCellularComponent	sperm flagellum	AKAP3 DNAH1 CFAP65 FSIP2 PACRG CFAP69 CTSH	8.78e-04	214	149	7	GO:0036126
GeneOntologyCellularComponent	cell projection membrane	ANK1 VEZT DOCK8 GRIN2A PIP5K1C MTMR6 BMX EGFR SLCO1A2 USH2A	1.07e-03	431	149	10	GO:0031253
HumanPheno	Coiled sperm flagella	AKAP3 DNAH1 CFAP65 FSIP2 CFAP69	1.35e-05	32	51	5	HP:0032560
HumanPheno	Short sperm flagella	AKAP3 DNAH1 CFAP65 FSIP2 CFAP69	1.58e-05	33	51	5	HP:0032559
HumanPheno	Abnormal sperm morphology	AKAP3 DNAH1 CFAP65 FSIP2 BRDT CFAP69	4.28e-05	66	51	6	HP:0012864
HumanPheno	Abnormal germ cell morphology	AKAP3 DNAH1 CFAP65 FSIP2 BRDT CFAP69	4.67e-05	67	51	6	HP:0012862
HumanPheno	Abnormal male germ cell morphology	AKAP3 DNAH1 CFAP65 FSIP2 BRDT CFAP69	4.67e-05	67	51	6	HP:0012863
HumanPheno	Abnormal sperm tail morphology	AKAP3 DNAH1 CFAP65 FSIP2 CFAP69	5.95e-05	43	51	5	HP:0012868
HumanPheno	Acute myelomonocytic leukemia	IDH1 SAMD9L	9.83e-05	2	51	2	HP:0004820
HumanPheno	Abnormal sperm motility	AKAP3 DNAH1 CFAP65 FSIP2 BRDT CFAP69 DNAH11	1.27e-04	115	51	7	HP:0012206
HumanPheno	Abnormal sperm physiology	AKAP3 DNAH1 CFAP65 FSIP2 BRDT CFAP69 DNAH11	1.27e-04	115	51	7	HP:0034809
HumanPheno	Absent sperm flagella	AKAP3 DNAH1 CFAP65 FSIP2	1.53e-04	28	51	4	HP:0032558
MousePheno	liver abscess	ANK1 NCF1C NCF1B	1.90e-05	7	116	3	MP:0003332
MousePheno	teratozoospermia	ADAD1 NUP210L AKAP3 LANCL1 KPNA6 IDE CFAP65 FSIP2 GUF1 BRDT ASPM CFAP69 VPS13B	3.32e-05	408	116	13	MP:0005578
MousePheno	asthenozoospermia	ADAD1 NUP210L AKAP3 LANCL1 C3orf20 DNAH1 CFAP65 FSIP2 GUF1 BRDT ASPM CFAP69	4.64e-05	362	116	12	MP:0002675
MousePheno	abnormal gustatory papillae morphology	BDNF DST EGFR	6.40e-05	10	116	3	MP:0006256
Domain	OLF	MYOC OLFM1 ADGRL2	1.24e-04	13	145	3	PF02191
Domain	OLF	MYOC OLFM1 ADGRL2	1.24e-04	13	145	3	PS51132
Domain	Olfac-like_dom	MYOC OLFM1 ADGRL2	1.24e-04	13	145	3	IPR003112
Domain	OLF	MYOC OLFM1 ADGRL2	1.24e-04	13	145	3	SM00284
Pubmed	Augmented EGF receptor tyrosine kinase activity impairs vascular function by NADPH oxidase-dependent mechanism in type 2 diabetic mouse.	EGFR NCF1C NCF1B	1.53e-06	6	149	3	26036345
Pubmed	An innate granuloma eradicates an environmental pathogen using Gsdmd and Nos2.	CASP7 NCF1C NCF1B	6.35e-06	9	149	3	37865673
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NRIP1 NR2C2 MYCBP2 BCOR DST ZFHX4 ZNF608 RGPD3 ABCD3 GCN1	1.40e-05	418	149	10	34709266
Pubmed	The beta- and gamma-isoforms of type I PIP5K regulate distinct stages of Ca2+ signaling in mast cells.	PIP5K1C PIP5K1B	1.82e-05	2	149	2	19549683
Pubmed	Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapy.	BRAF EGFR	1.82e-05	2	149	2	32394048
Pubmed	Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity.	BRAF EGFR	1.82e-05	2	149	2	31911540
Pubmed	Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.	BRAF EGFR	1.82e-05	2	149	2	30963570
Pubmed	Adult mouse subventricular zone stem and progenitor cells are sessile and epidermal growth factor receptor negatively regulates neuroblast migration.	NRIP1 EGFR	1.82e-05	2	149	2	19956583
Pubmed	Detection of EGFR mutations and EML4-ALK rearrangements in lung adenocarcinomas using archived cytological slides.	EML4 EGFR	1.82e-05	2	149	2	23408463
Pubmed	Modulation of testicular receptor 4 activity by mitogen-activated protein kinase-mediated phosphorylation.	NRIP1 NR2C2	1.82e-05	2	149	2	16887930
Pubmed	Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.	IDH1 BRAF	1.82e-05	2	149	2	19543740
Pubmed	Phosphorylation of Mps1 by BRAFV600E prevents Mps1 degradation and contributes to chromosome instability in melanoma.	TTK BRAF	1.82e-05	2	149	2	22430208
Pubmed	First case of combined small-cell lung cancer with adenocarcinoma harboring EML4-ALK fusion and an exon 19 EGFR mutation in each histological component.	EML4 EGFR	1.82e-05	2	149	2	23154565
Pubmed	Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistry.	IDH1 BRAF	1.82e-05	2	149	2	25634750
Pubmed	Multiorgan failure with abnormal receptor metabolism in mice mimicking Samd9/9L syndromes.	SAMD9L EGFR	1.82e-05	2	149	2	33373325
Pubmed	Frequent BRAF or EGFR Mutations in Ciliated Muconodular Papillary Tumors of the Lung.	BRAF EGFR	1.82e-05	2	149	2	26718882
Pubmed	Poly(amido amine) is an ideal carrier of miR-7 for enhancing gene silencing effects on the EGFR pathway in U251 glioma cells.	LILRB1 EGFR	1.82e-05	2	149	2	23404538
Pubmed	Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.	IDH1 EGFR	1.82e-05	2	149	2	31542863
Pubmed	Rectal and colon cancer: Not just a different anatomic site.	BRAF EGFR	1.82e-05	2	149	2	26145760
Pubmed	New IDH1 I113T mutation associated with BRAF V600E mutation: new driver of gliomagenesis?	IDH1 BRAF	1.82e-05	2	149	2	24857351
Pubmed	Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation.	IDH1 BRAF	1.82e-05	2	149	2	21356389
Pubmed	BRAF and EGFR inhibitors synergize to increase cytotoxic effects and decrease stem cell capacities in BRAF(V600E)-mutant colorectal cancer cells.	BRAF EGFR	1.82e-05	2	149	2	29534162
Pubmed	B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells.	TTK BRAF	1.82e-05	2	149	2	18071315
Pubmed	Functional pseudogenes inhibit the superoxide production.	NCF1C NCF1B	1.82e-05	2	149	2	26086043
Pubmed	Brain-derived neurotrophic factor restores long-term potentiation in polysialic acid-neural cell adhesion molecule-deficient hippocampus.	NCAM1 BDNF	1.82e-05	2	149	2	10760298
Pubmed	Combined "Infiltrating Astrocytoma/Pleomorphic Xanthoastrocytoma" Harboring IDH1 R132H and BRAF V600E Mutations.	IDH1 BRAF	1.82e-05	2	149	2	26414224
Pubmed	Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants.	BRAF EGFR	1.82e-05	2	149	2	29915264
Pubmed	Brain-derived neurotrophic factor (BDNF) and polysialylated-neural cell adhesion molecule (PSA-NCAM): codistribution in the human brainstem precerebellar nuclei from prenatal to adult age.	NCAM1 BDNF	1.82e-05	2	149	2	20932956
Pubmed	Restoration of synaptic plasticity and learning in young and aged NCAM-deficient mice by enhancing neurotransmission mediated by GluN2A-containing NMDA receptors.	NCAM1 GRIN2A	1.82e-05	2	149	2	22396402
Pubmed	BRAF overexpression induces rampant glioma proliferation independent of phospho-EGFR expression.	BRAF EGFR	1.82e-05	2	149	2	25618114
Pubmed	Mutations in DNAH1, which encodes an inner arm heavy chain dynein, lead to male infertility from multiple morphological abnormalities of the sperm flagella.	DNAH1 DNAH11	1.82e-05	2	149	2	24360805
Pubmed	Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial.	BRAF EGFR	1.82e-05	2	149	2	25430497
Pubmed	EGFR and BRAF mutations in inverted sinonasal papilloma - a more complex landscape?	BRAF EGFR	1.82e-05	2	149	2	33048186
Pubmed	NR2A but not NR2B N-methyl-D-aspartate receptor subunit is altered in the visual cortex of BDNF-knock-out mice.	GRIN2A BDNF	1.82e-05	2	149	2	12735629
Pubmed	Genetically engineered fusion of MAP-1 and factor H domains 1-5 generates a potent dual upstream inhibitor of both the lectin and alternative complement pathways.	CFH MASP1	1.82e-05	2	149	2	26260032
Pubmed	Uncommon V599E BRAF mutations in Japanese patients with lung cancer.	BRAF EGFR	1.82e-05	2	149	2	16376942
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NRIP1 MYCBP2 VEZT CAPZA1 IDE GRHL2 ITFG1 DNAH1 PLEKHG4B INTS6 ZNF608 EGFR PLCB4 TANGO2 MCF2L PACRG CFAP69 PMF1 VPS13B	2.17e-05	1489	149	19	28611215
Pubmed	Ischemic stroke is associated with the ABO locus: the EuroCLOT study.	CFH ASPM MCF2L	2.71e-05	14	149	3	23381943
Pubmed	No replication of genetic association between candidate polymorphisms and Alzheimer's disease.	IDE ECE1 BDNF	4.14e-05	16	149	3	19889475
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	MASP1 NEK7 IDE STAM GRHL2 ITFG1 FCHSD2 SAMD9L PLCB4 CTSH FGD6 VPS13B	4.28e-05	686	149	12	29987050
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYCBP2 VEZT KPNA6 IDE PSTPIP2 STAM BCOR MTMR6 CSE1L EGFR PTPRM UBTF ABCD3 ADGRL2 GCN1	4.79e-05	1049	149	15	27880917
Pubmed	NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.	NCF1C NCF1B	5.45e-05	3	149	2	18787174
Pubmed	Deficient production of reactive oxygen species leads to severe chronic DSS-induced colitis in Ncf1/p47phox-mutant mice.	NCF1C NCF1B	5.45e-05	3	149	2	24873968
Pubmed	Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis.	NCF1C NCF1B	5.45e-05	3	149	2	20142487
Pubmed	p47(phox) contributes to albuminuria and kidney fibrosis in mice.	NCF1C NCF1B	5.45e-05	3	149	2	25565313
Pubmed	Knockout of neutrophil cytosolic factor 1 ameliorates neuroinflammation and motor deficit after traumatic brain injury.	NCF1C NCF1B	5.45e-05	3	149	2	39357591
Pubmed	Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells.	NCF1C NCF1B	5.45e-05	3	149	2	11435342
Pubmed	Virulence comparisons of Aspergillus nidulans mutants are confounded by the inflammatory response of p47phox-/- mice.	NCF1C NCF1B	5.45e-05	3	149	2	16041040
Pubmed	Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion.	NCF1C NCF1B	5.45e-05	3	149	2	17307863
Pubmed	Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.	NCF1C NCF1B	5.45e-05	3	149	2	27829407
Pubmed	Oncogenic B-Raf(V600E) abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells.	TTK BRAF	5.45e-05	3	149	2	23726842
Pubmed	Analysis of KRAS, BRAF, and EGFR mutational status in respiratory epithelial adenomatoid hamartoma (REAH).	BRAF EGFR	5.45e-05	3	149	2	36504219
Pubmed	EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.	BRAF EGFR	5.45e-05	3	149	2	19584155
Pubmed	The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.	NCF1C NCF1B	5.45e-05	3	149	2	22376231
Pubmed	Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.	NCF1C NCF1B	5.45e-05	3	149	2	12364355
Pubmed	P47(phox)-deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J-m db/db and db/+.	NCF1C NCF1B	5.45e-05	3	149	2	10670582
Pubmed	Direct Comparison of a Natural Loss-Of-Function Single Nucleotide Polymorphism with a Targeted Deletion in the Ncf1 Gene Reveals Different Phenotypes.	NCF1C NCF1B	5.45e-05	3	149	2	26528554
Pubmed	The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis.	NCF1C NCF1B	5.45e-05	3	149	2	19052348
Pubmed	Effect of early particulate air pollution exposure on obesity in mice: role of p47phox.	NCF1C NCF1B	5.45e-05	3	149	2	20864666
Pubmed	Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-deficient mice.	NCF1C NCF1B	5.45e-05	3	149	2	17114280
Pubmed	Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.	NCF1C NCF1B	5.45e-05	3	149	2	17332431
Pubmed	Lpp of Escherichia coli K1 inhibits host ROS production to counteract neutrophil-mediated elimination.	NCF1C NCF1B	5.45e-05	3	149	2	36592568
Pubmed	Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression.	NCF1C NCF1B	5.45e-05	3	149	2	30504842
Pubmed	Direct interaction of HIV gp120 with neuronal CXCR4 and CCR5 receptors induces cofilin-actin rod pathology via a cellular prion protein- and NOX-dependent mechanism.	NCF1C NCF1B	5.45e-05	3	149	2	33705493
Pubmed	A PCR-Based Approach for Driver Mutation Analysis of EGFR, KRAS, and BRAF Genes in Lung Cancer Tissue Sections.	BRAF EGFR	5.45e-05	3	149	2	33683689
Pubmed	Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: studies on NADPH oxidase knockout mice.	NCF1C NCF1B	5.45e-05	3	149	2	15513930
Pubmed	Phosphoinositide 3-kinase regulates the phosphorylation of NADPH oxidase component p47(phox) by controlling cPKC/PKCdelta but not Akt.	NCF1C NCF1B	5.45e-05	3	149	2	15033459
Pubmed	Clinical profile and outcomes of patients with Stage IV adenocarcinoma of lung: A tertiary cancer center experience.	EML4 EGFR	5.45e-05	3	149	2	29199690
Pubmed	p47phox Phox homology domain regulates plasma membrane but not phagosome neutrophil NADPH oxidase activation.	NCF1C NCF1B	5.45e-05	3	149	2	20817944
Pubmed	Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.	IDH1 EGFR	5.45e-05	3	149	2	25964481
Pubmed	Prolonged production of reactive oxygen species in response to B cell receptor stimulation promotes B cell activation and proliferation.	NCF1C NCF1B	5.45e-05	3	149	2	23024271
Pubmed	Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene.	NCF1C NCF1B	5.45e-05	3	149	2	15310853
Pubmed	Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice.	NCF1C NCF1B	5.45e-05	3	149	2	34970267
Pubmed	Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility.	NCF1C NCF1B	5.45e-05	3	149	2	25689796
Pubmed	Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.	NCF1C NCF1B	5.45e-05	3	149	2	14993144
Pubmed	The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression.	NCF1C NCF1B	5.45e-05	3	149	2	12031896
Pubmed	Ncf1 (p47phox) polymorphism determines oxidative burst and the severity of arthritis in rats and mice.	NCF1C NCF1B	5.45e-05	3	149	2	15936744
Pubmed	Targeting BRAF aberrations in advanced colorectal carcinoma: from bench to bedside.	BRAF EGFR	5.45e-05	3	149	2	26616508
Pubmed	NADPH oxidase p47phox siRNA attenuates adventitial fibroblasts proliferation and migration in apoE(-/-) mouse.	NCF1C NCF1B	5.45e-05	3	149	2	25628043
Pubmed	Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.	EML4 EGFR	5.45e-05	3	149	2	22736493
Pubmed	Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit.	NCF1C NCF1B	5.45e-05	3	149	2	12560337
Pubmed	Inhibition of endothelial Nox2 activation by LMH001 protects mice from angiotensin II-induced vascular oxidative stress, hypertension and aortic aneurysm.	NCF1C NCF1B	5.45e-05	3	149	2	35276443
Pubmed	Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox(-/-) mice.	NCF1C NCF1B	5.45e-05	3	149	2	19381132
Pubmed	Neural cell adhesion molecule-180-mediated homophilic binding induces epidermal growth factor receptor (EGFR) down-regulation and uncouples the inhibitory function of EGFR in neurite outgrowth.	NCAM1 EGFR	5.45e-05	3	149	2	17995934
Pubmed	Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice.	NCF1C NCF1B	5.45e-05	3	149	2	10799876
Pubmed	Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma.	BRAF EGFR	5.45e-05	3	149	2	23242808
Pubmed	Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha.	NCF1C NCF1B	5.45e-05	3	149	2	11834706
Pubmed	Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment.	BRAF EGFR	5.45e-05	3	149	2	25628445
Pubmed	Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease.	NCF1C NCF1B	5.45e-05	3	149	2	19635825
Pubmed	The NCF1 variant p.R90H aggravates autoimmunity by facilitating the activation of plasmacytoid dendritic cells.	NCF1C NCF1B	5.45e-05	3	149	2	35788118
Pubmed	Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation.	NCF1C NCF1B	5.45e-05	3	149	2	17310103
Pubmed	Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors.	NCF1C NCF1B	5.45e-05	3	149	2	24358335
Pubmed	Molecular characterization of the mouse p47-phox (Ncf1) gene and comparative analysis of the mouse p47-phox (Ncf1) gene to the human NCF1 gene.	NCF1C NCF1B	5.45e-05	3	149	2	10891396
Pubmed	NAD(P)H oxidase subunit p47phox is elevated, and p47phox knockout prevents diaphragm contractile dysfunction in heart failure.	NCF1C NCF1B	5.45e-05	3	149	2	26209274
Pubmed	Dihydrolipoamide dehydrogenase of Pseudomonas aeruginosa is a surface-exposed immune evasion protein that binds three members of the factor H family and plasminogen.	CFH PLG	5.45e-05	3	149	2	23071278
Pubmed	NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease.	NCF1C NCF1B	5.45e-05	3	149	2	11018074
Pubmed	Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease.	NCF1C NCF1B	5.45e-05	3	149	2	9116268
Pubmed	Mice producing less reactive oxygen species are relatively resistant to collagen glycopeptide vaccination against arthritis.	NCF1C NCF1B	5.45e-05	3	149	2	20686129
Pubmed	Angiotensin II induced catabolic effect and muscle atrophy are redox dependent.	NCF1C NCF1B	5.45e-05	3	149	2	21570954
Pubmed	Female mice lacking p47phox have altered adipose tissue gene expression and are protected against high fat-induced obesity.	NCF1C NCF1B	5.45e-05	3	149	2	23482812
Interaction	PMS2P3 interactions	FOCAD MTMR6 ASPM	6.89e-06	6	143	3	int:PMS2P3
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NRIP1 MYCBP2 DDX42 NEK7 STAM TTK BDNF FCHSD2 THBS2 CSE1L DST EGFR PTPRM ARHGEF10 UGCG NAV3 PLCB4 PHIP VPS13B	3.46e-07	856	147	19	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	BDNF DST ARHGEF10 NAV3 PLCB4 VPS13B	8.53e-06	85	147	6	M10575
Coexpression	GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP	CASP7 TMEM106A DST PPT2 EGFR PTPRM NAV3 PMF1	1.02e-05	185	147	8	M8792
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_100	ANO4 CFH NCAM1 THBS2 NAV3	1.42e-05	46	143	5	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100_k5
CoexpressionAtlas	B cells, B.Fo.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23+, Spleen, avg-3	THEMIS2 DENND4A SLF1 EML4 DGKA FCHSD2 SAMD9L ZNF608 PIP5K1B CTSH NCF1C	2.27e-05	345	143	11	GSM538201_500
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SLF1 ECE1 DST ZNF608 PTPRM PLCB4 MCF2L ADGRL2 FGD6 FAM135A	1.54e-09	200	149	10	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 ANK1 PTCHD4 GRHL2 MTMR6 PTPRM ASPM AGBL1	1.66e-07	179	149	8	d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 DNAH1 CAPN8 ZFHX4 NRXN1 NAV3 USH2A DNAH11	2.05e-07	184	149	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 DNAH1 CAPN8 ZFHX4 NRXN1 NAV3 USH2A DNAH11	2.05e-07	184	149	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 DNAH1 CAPN8 ZFHX4 NRXN1 NAV3 USH2A DNAH11	2.05e-07	184	149	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	NCAM1 TENM2 DST PTPRM PIP5K1B PACRG ADGRL2 CACNA2D3	2.61e-07	190	149	8	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH NRIP1 DENND4A DOCK8 FCHSD2 DST NAV3 ADGRL2	2.94e-07	193	149	8	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 ANK1 PTCHD4 ZNF608 EGFR PTPRM ASPM PIP5K1B	2.94e-07	193	149	8	9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH NRIP1 DENND4A DOCK8 FCHSD2 DST NAV3 ADGRL2	2.94e-07	193	149	8	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH NRIP1 DENND4A DOCK8 FCHSD2 DST NAV3 ADGRL2	2.94e-07	193	149	8	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH NRIP1 DENND4A DOCK8 FCHSD2 DST NAV3 ADGRL2	2.94e-07	193	149	8	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLF1 ECE1 DST ZNF608 PTPRM PLCB4 MCF2L ADGRL2	3.06e-07	194	149	8	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SPATA6L GRHL2 CAPN8 EGFR PTPRM PIP5K1B CTSH AGBL1	3.72e-07	199	149	8	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	GBP6 SLF1 ECE1 ZNF608 PTPRM UGCG MCF2L ADGRL2	3.86e-07	200	149	8	6f531a418ff25b59a543800cf4bce7b72404ce08
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	GBP6 SLF1 ECE1 SAMD9L ZNF608 PTPRM UGCG ADGRL2	3.86e-07	200	149	8	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SLF1 ECE1 DST ZNF608 PTPRM PLCB4 MCF2L ADGRL2	3.86e-07	200	149	8	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLF1 ECE1 DST ZNF608 PTPRM PLCB4 MCF2L FAM135A	3.86e-07	200	149	8	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SLF1 ECE1 DST ZNF608 PTPRM PLCB4 MCF2L ADGRL2	3.86e-07	200	149	8	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SLF1 ECE1 DST ZNF608 PTPRM PLCB4 MCF2L ADGRL2	3.86e-07	200	149	8	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIS18BP1 MFSD6 S1PR2 GRHL2 TENM2 ASPM SKA1	2.45e-06	179	149	7	4166c4e1a8748a79ac6a11fd0b97c5344be2321b
ToppCell	LV\|World / Chamber and Cluster_Paper	NCAM1 TENM2 BDNF PIP5K1B PLCB4 PACRG ADGRL2	2.54e-06	180	149	7	5ac6f485a58bb29462fec02dfbe8eb70864eafe3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRIN2A PTCHD4 SLCO1A2 PIP5K1B PLCB4 MCF2L CACNA2D3	2.73e-06	182	149	7	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 ANK1 PTCHD4 GRHL2 PTPRM ASPM AGBL1	2.73e-06	182	149	7	a3c5c0eff527c8d3848acda14af8f9e99c69b0de
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	ECE1 PTCHD4 PTPRM NAV3 PLCB4 MCF2L ADGRL2	3.27e-06	187	149	7	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAM1 ECE1 TENM2 KY DST NRXN1 FAM151A	3.38e-06	188	149	7	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	NCAM1 TENM2 DST PTPRM PIP5K1B PACRG ADGRL2	3.75e-06	191	149	7	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 ANK1 PTCHD4 ZNF608 EGFR PTPRM PIP5K1B	3.89e-06	192	149	7	bf1943715085c4124b1675888b0615c9500ec888
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLF1 HLCS ZNF608 PTPRM PLCB4 MCF2L ADGRL2	4.02e-06	193	149	7	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ECE1 ZNF608 PTPRM NAV3 PLCB4 MCF2L ADGRL2	4.16e-06	194	149	7	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 ANK1 PTCHD4 ZNF608 EGFR PTPRM PIP5K1B	4.16e-06	194	149	7	02a9cc821c2b14aa7d0e55661a5fab66364474e1
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NEK7 TENM2 DST ZFHX4 EGFR SLFN13 ADGRL2	4.30e-06	195	149	7	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRIN2A TENM2 FOCAD NRXN1 NAV3 OLFM1 CACNA2D3	4.30e-06	195	149	7	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	(08)_PNEC\|World / shred by cell type and Timepoint	ANK1 NCAM1 NRXN1 STMN3 OLFM1 PIP5K1B MCF2L	4.45e-06	196	149	7	2ee37155c03cd5009427a4bffe6c80ed2ac6939e
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRIN2A TENM2 FOCAD NRXN1 OLFM1 ADGRL2 CACNA2D3	4.76e-06	198	149	7	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SPATA6L GRHL2 CAPN8 EGFR PIP5K1B CTSH AGBL1	4.92e-06	199	149	7	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SPATA6L GRHL2 CAPN8 EGFR PIP5K1B CTSH AGBL1	4.92e-06	199	149	7	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ECE1 DST ZNF608 PTPRM PLCB4 MCF2L ADGRL2	5.08e-06	200	149	7	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	Neuronal-Inhibitory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANO4 ANK1 PTCHD4 ZNF608 EGFR PTPRM PIP5K1B	5.08e-06	200	149	7	9ff8647e2de0b538e15929dca88ebb20ff7ab043
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GBP6 ECE1 SAMD9L ZNF608 PTPRM UGCG MCF2L	5.08e-06	200	149	7	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ECE1 DST ZNF608 PTPRM PLCB4 MCF2L ADGRL2	5.08e-06	200	149	7	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GBP6 SAMD9L DST ZNF608 PTPRM ARHGEF10 ADGRL2	5.08e-06	200	149	7	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLF1 ECE1 DST PTPRM PLCB4 MCF2L ADGRL2	5.08e-06	200	149	7	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLF1 ECE1 DST PTPRM PLCB4 MCF2L ADGRL2	5.08e-06	200	149	7	60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NUP210L NCAM1 GRHL2 DNAH1 SLFN13 PIP5K1B	6.30e-06	135	149	6	b444005987093efab3265201b3541d7941816cc2
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IMPG1 TTK BMX PLG SKA1 AGBL1	9.12e-06	144	149	6	e9d62f202f0fa8747961036ef0eafed91fe8a42f
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	DPY19L3 GRIN2A PIP5K1C PHAF1 FCHSD2 USH2A	1.55e-05	158	149	6	1f94622186d8329357fa06785e03eeacf29ab1ce
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	NUP210L TENM2 NRXN1 NAV3 USH2A AGBL1	1.60e-05	159	149	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Marrow-T_cells-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IDH1 TMEM106A PTPRM SMPDL3A OLFM1 CTSH	1.85e-05	163	149	6	30cd95d4f37bd54c1fde54960cb005db58bdd30c
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MIS18BP1 DGKA PSTPIP2 BCOR SAMD9L MUL1	1.85e-05	163	149	6	130c84bca3f72ab7d1a4fee2990c3d01600318ed
ToppCell	facs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IDH1 TMEM106A PTPRM SMPDL3A OLFM1 CTSH	1.85e-05	163	149	6	ab934cb986495adfc8dbe5a276577f2a8fb6ee03
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPATA6L C3orf20 DNAH1 PACRG CFAP69 DNAH11	2.26e-05	169	149	6	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH IDH1 TMEM106A SMPDL3A OLFM1 CTSH	2.58e-05	173	149	6	807183fc23478da9451906dacd88de4e73112e0d
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH IDH1 TMEM106A SMPDL3A OLFM1 CTSH	2.58e-05	173	149	6	2e683ec555dc0036875e0f5674dcc5e93ead205d
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIS18BP1 PGLYRP4 NCAM1 TTK ASPM SKA1	2.67e-05	174	149	6	9d5dcd46cf346c381dea68ada6665f7fb68114a3
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIS18BP1 PGLYRP4 NCAM1 TTK ASPM SKA1	2.67e-05	174	149	6	53cec5c666c45278a71c21dd9c62a052a97e0fdf
ToppCell	droplet-Marrow-BM-30m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH IDH1 TMEM106A SMPDL3A OLFM1 CTSH	2.67e-05	174	149	6	118ba2729ecc6aa1bb8548f3cf537b3f9e902ef0
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH IDH1 PSTPIP2 TMEM106A SMPDL3A OLFM1	2.75e-05	175	149	6	69b59ec58e64644deb7e07f31ef495ef4a6f6276
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH IDH1 PSTPIP2 TMEM106A SMPDL3A OLFM1	2.75e-05	175	149	6	4f7498b5a0ed52c348a5f94bcd41d830ba7954ea
ToppCell	wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	KY NRXN1 ZNF804B OLFM1 PLCB4 MAB21L1	2.94e-05	177	149	6	15a5c96ea840376e54933ebe7a8334a11d9ce411
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NRIP1 ZNF569 NEK7 MTMR6 BRAF THG1L	3.03e-05	178	149	6	8151e5d73407fd9cba382b69a2bc707c81790c7f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TMEM106A ZNF804B KCNK5 PLG MCF2L CTSH	3.22e-05	180	149	6	f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e
ToppCell	facs-SCAT\|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP6 TMEM106A THBS2 ZFHX4 KCNK5 MAB21L1	3.22e-05	180	149	6	6c70b6b7480507fa94625013222ad338ee7dd1d9
ToppCell	390C-Fibroblasts-Fibroblast-G\|390C / Donor, Lineage, Cell class and subclass (all cells)	CFH MASP1 MYOC S1PR2 PTCHD4 DST	3.22e-05	180	149	6	137fc14859c89e1ecd98bee388bb58c04b835847
ToppCell	390C-Fibroblasts-Fibroblast-G-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CFH MASP1 MYOC S1PR2 PTCHD4 DST	3.22e-05	180	149	6	cd6790de050151fedfa2c5ea6ad58b72665414b2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRIN2A PTCHD4 SLCO1A2 PIP5K1B PLCB4 CACNA2D3	3.33e-05	181	149	6	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 DOCK8 EML4 PSTPIP2 SAMD9L ZNF608	3.43e-05	182	149	6	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VEZT NCAM1 GRHL2 NRXN1 KCNK5 GCN1	3.43e-05	182	149	6	6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517
ToppCell	droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SAMD9L ZNF608 PTPRM NAV3 PLCB4 MCF2L	3.43e-05	182	149	6	81279877b920b5a1bc991a07d3031d6458700fe3
ToppCell	facs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ECE1 BMX DST SMPDL3A CTSH FAM135A	3.43e-05	182	149	6	aa113a0d2c1d28bda24cbb1221afd21b5628dc6d
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH NCAM1 ECE1 BMX UGCG CTSH	3.54e-05	183	149	6	b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	GRHL2 CAPN8 EGFR PIP5K1B CTSH AGBL1	3.65e-05	184	149	6	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CFH TENM2 THBS2 PLCB4 MAB21L1 CACNA2D3	3.76e-05	185	149	6	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	EML4 STAM CAPN8 PIP5K1B CTSH AGBL1	3.99e-05	187	149	6	030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	ANO4 CFH TENM2 DST NAV3 ADGRL2	3.99e-05	187	149	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	COVID-19-kidney-CD-IC-B\|kidney / Disease (COVID-19 only), tissue and cell type	ANO4 GRIN2A EGFR PIP5K1B PACRG DNAH11	3.99e-05	187	149	6	ce05b89860573fe0356102e2998d1ef6d1968034
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC2\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THEMIS2 PSTPIP2 HORMAD1 LILRB1 CTSH CACNA2D3	4.11e-05	188	149	6	c7c2cf1aa328e735073d6031e44b5dbd55beae6d
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ECE1 PTPRM NAV3 PLCB4 MCF2L ADGRL2	4.11e-05	188	149	6	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	NCAM1 TENM2 BDNF PIP5K1B PACRG ADGRL2	4.11e-05	188	149	6	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SPATA6L GRHL2 CAPN8 EGFR PIP5K1B DNAH11	4.11e-05	188	149	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPATA6L GRHL2 EGFR SLCO1A2 CACNA2D3 DNAH11	4.11e-05	188	149	6	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 ANK1 PTCHD4 MTMR6 PTPRM ASPM	4.11e-05	188	149	6	8de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	NCAM1 TENM2 PIP5K1B PACRG ADGRL2 CACNA2D3	4.23e-05	189	149	6	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	NCAM1 TENM2 PTPRM PIP5K1B PACRG ADGRL2	4.23e-05	189	149	6	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 ANK1 LANCL1 PTCHD4 PTPRM ASPM	4.23e-05	189	149	6	99a13b1b669b0cd36e3096632351d9ade25d1173
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 ANK1 ZNF608 PTPRM PIP5K1B AGBL1	4.36e-05	190	149	6	26843ec1d19ac85a50990705353b802745d33e4d
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	ECE1 PTPRM ARHGEF10 PLCB4 MCF2L ADGRL2	4.36e-05	190	149	6	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	NCAM1 TENM2 PTPRM PIP5K1B PACRG ADGRL2	4.36e-05	190	149	6	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NMUR2 ECE1 UGCG PLCB4 MCF2L ADGRL2	4.36e-05	190	149	6	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPATA6L GRHL2 CAPN8 PIP5K1B CTSH AGBL1	4.36e-05	190	149	6	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLF1 ZNF608 PTPRM ARHGEF10 PLCB4 ADGRL2	4.36e-05	190	149	6	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 ANK1 LANCL1 PTCHD4 PTPRM ASPM	4.36e-05	190	149	6	8c9c230a509afaeee50644153974a5642b01a2b8
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 EML4 FCHSD2 SAMD9L ZNF608 CTSH	4.36e-05	190	149	6	ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAM1 ECE1 KY DST NRXN1 FAM151A	4.49e-05	191	149	6	3387b95a3f2445c672d407922fdce3a91eabaef8
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	SPATA6L GRHL2 CAPN8 PIP5K1B CTSH AGBL1	4.49e-05	191	149	6	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLF1 ZNF608 PTPRM UGCG PLCB4 ADGRL2	4.49e-05	191	149	6	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPATA6L GRHL2 CAPN8 ZNF608 EGFR PIP5K1B	4.49e-05	191	149	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAM1 ECE1 KY DST NRXN1 FAM151A	4.49e-05	191	149	6	a251b134f67a0a1ef3a42f50042f128a17f20b22
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MIS18BP1 IMPG1 TTK ASPM SKA1 PMF1	4.62e-05	192	149	6	52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	SPATA6L GRHL2 CAPN8 EGFR PIP5K1B AGBL1	4.62e-05	192	149	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPATA6L GRHL2 CAPN8 PIP5K1B CTSH AGBL1	4.62e-05	192	149	6	cc9911e182a289779a2612bc213daae5607689e7
Disease	Colorectal Carcinoma	ZNF569 WNT8B AKAP3 GRIN2A IDH1 STAM CSE1L BRAF EGFR SLCO1A2 ABCD3 ZNF432 CTSH PHIP	9.36e-06	702	144	14	C0009402
Disease	Malignant neoplasm of brain	EML4 IDH1 BRAF EGFR	3.53e-05	38	144	4	C0153633
Disease	Brain Neoplasms	EML4 IDH1 BRAF EGFR	3.92e-05	39	144	4	C0006118
Disease	coagulation factor measurement	CFH ASPM MCF2L	1.22e-04	20	144	3	EFO_0004634
Disease	chronic granulomatous disease (implicated_via_orthology)	NCF1C NCF1B	2.34e-04	5	144	2	DOID:3265 (implicated_via_orthology)
Disease	Cetuximab response	BRAF EGFR	2.34e-04	5	144	2	cv:CN077967
Disease	Panitumumab response	BRAF EGFR	2.34e-04	5	144	2	cv:CN077999
Disease	Cholangiocarcinoma	IDH1 BRAF EGFR	2.73e-04	26	144	3	C0206698
Disease	diabetes mellitus	ANO4 ANK1 MYCBP2 IDE	3.48e-04	68	144	4	EFO_0000400
Disease	thrombospondin-2 measurement	CFH THBS2	3.50e-04	6	144	2	EFO_0008299
Disease	voltage-dependent calcium channel subunit alpha-2/delta-3 measurement	CFH CACNA2D3	3.50e-04	6	144	2	EFO_0802218
Disease	primary open angle glaucoma (is_marker_for)	MYOC BDNF	3.50e-04	6	144	2	DOID:1070 (is_marker_for)
Disease	triacylglycerol 54:1 measurement	ZFHX4 ZNF432	1.04e-03	10	144	2	EFO_0010419
Disease	complement factor H-related protein 5 measurement	CFH ADAM5 THG1L	1.14e-03	42	144	3	EFO_0008098
Disease	Semantic-Pragmatic Disorder	GRIN2A NRXN1	1.26e-03	11	144	2	C0454655
Disease	Auditory Processing Disorder, Central	GRIN2A NRXN1	1.26e-03	11	144	2	C0751257
Disease	hyperhomocysteinemia (implicated_via_orthology)	GRIN2A ECE1	1.26e-03	11	144	2	DOID:9279 (implicated_via_orthology)
Disease	Language Delay	GRIN2A NRXN1	1.26e-03	11	144	2	C0023012
Disease	Language Development Disorders	GRIN2A NRXN1	1.26e-03	11	144	2	C0023014
Disease	hemopexin measurement	CFH NEK7	1.26e-03	11	144	2	EFO_0008149
Disease	quality of life during menstruation measurement, dysmenorrheic pain measurement	GRIN2A VPS13B	1.26e-03	11	144	2	EFO_0007889, EFO_0009366
Disease	Speech Delay	GRIN2A NRXN1	1.26e-03	11	144	2	C0241210
Disease	coffee consumption measurement, tea consumption measurement	NCAM1 HORMAD1 BDNF	1.30e-03	44	144	3	EFO_0006781, EFO_0010091
Disease	high grade glioma (implicated_via_orthology)	IDH1 BRAF EGFR	1.30e-03	44	144	3	DOID:3070 (implicated_via_orthology)
Disease	chronotype measurement	MYCBP2 CAPZA1 NMUR2 ECE1 TENM2 DNAH1 NAA25 NRXN1 KCNJ4 NAV3 SLC15A5 PLCB4	1.33e-03	882	144	12	EFO_0008328
Disease	rheumatoid arthritis (implicated_via_orthology)	NCF1C NCF1B	1.51e-03	12	144	2	DOID:7148 (implicated_via_orthology)
Disease	susceptibility to childhood ear infection measurement	PTCHD4 TENM2 SLCO1A2 PLG VPS13B	1.55e-03	171	144	5	EFO_0007904
Disease	cognitive function measurement	PTGES2 DENND4A NUP210L NCAM1 GRIN2A CAPN8 THBS2 CSE1L NRXN1 ZNF608 ARHGEF10 KCNJ4 PACRG USH2A AGBL1 CACNA2D3	1.75e-03	1434	144	16	EFO_0008354
Disease	complement factor H-related protein 4 measurement	CFH ASPM ADGRL2	1.78e-03	49	144	3	EFO_0600091
Disease	diet measurement	NUP210L MFSD6 NCAM1 TENM2 CAPN8 DST ZNF608 KCNJ4 ZNF432 KCNK5 OLFM1 ADGRL2 AGBL1	1.94e-03	1049	144	13	EFO_0008111
Disease	Neoplasm of lung	BRAF EGFR	2.07e-03	14	144	2	cv:C0024121
Disease	Lung cancer	BRAF EGFR	2.07e-03	14	144	2	cv:C0242379
Disease	LUNG CANCER	BRAF EGFR	2.07e-03	14	144	2	211980
Disease	wet macular degeneration	CFH FGD6	2.07e-03	14	144	2	EFO_0004683
Disease	Alcoholic Intoxication, Chronic	NCAM1 GRIN2A NMUR2 BDNF AGO1 EGFR	2.08e-03	268	144	6	C0001973
Disease	cancer (implicated_via_orthology)	IDH1 PIP5K1C DST BRAF THG1L PIP5K1B	2.08e-03	268	144	6	DOID:162 (implicated_via_orthology)
Disease	response to tenofovir, creatinine clearance measurement	OR5T3 BRAF OLFM1 ADGRL2	2.25e-03	112	144	4	EFO_0007934, EFO_0009279
Disease	mannan-binding lectin serine protease 1 measurement	CFH MASP1	2.38e-03	15	144	2	EFO_0008223
Disease	Colorectal Neoplasms	ZNF569 GRIN2A BRAF EGFR ABCD3 ZNF432	2.45e-03	277	144	6	C0009404
Disease	Cleft palate, cleft lip	NEK7 GRHL2 TENM2 NAA25 TANGO2 VPS13B	2.54e-03	279	144	6	EFO_0003959, HP_0000175
Disease	gliosarcoma	IDH1 EGFR	2.71e-03	16	144	2	C0206726
Disease	longevity	ECE1 CSE1L BRAF NRXN1 CFAP69 PMF1	2.78e-03	284	144	6	EFO_0004300
Disease	nicotine dependence symptom count	EPHB3 MYCBP2 FCHSD2 NRXN1 EGFR PTPRM	2.83e-03	285	144	6	EFO_0009262
Disease	Alzheimer's disease (biomarker_via_orthology)	NCAM1 IDE BDNF	2.89e-03	58	144	3	DOID:10652 (biomarker_via_orthology)
Disease	colorectal cancer (is_implicated_in)	GRIN2A BCOR BRAF EGFR	2.97e-03	121	144	4	DOID:9256 (is_implicated_in)
Disease	uric acid measurement	HBP1 TENM2 BDNF NAA25 UBTF KCNK5 PIP5K1B ADGRL2 CACNA2D3	3.14e-03	610	144	9	EFO_0004761
Disease	angina pectoris	CFH NAA25 PLG FGD6	3.34e-03	125	144	4	EFO_0003913
Disease	Adrenocortical carcinoma	BRAF EGFR	3.44e-03	18	144	2	C0206686
Disease	alcohol use disorder measurement	NCAM1 LILRB1 TENM2 BDNF PHIP	4.08e-03	214	144	5	EFO_0009458
Disease	Adenocarcinoma of prostate	BRAF EGFR	4.24e-03	20	144	2	C0007112
Disease	risk-taking behaviour	NEK7 NCAM1 GRIN2A TENM2 BDNF PPT2 NRXN1 ZNF608 PTPRM KCNJ4	4.39e-03	764	144	10	EFO_0008579
Disease	cannabis dependence	PTGES2 NCAM1 TENM2 BDNF	4.39e-03	135	144	4	EFO_0007191
Disease	COVID-19 (is_implicated_in)	CFH PLG	4.67e-03	21	144	2	DOID:0080600 (is_implicated_in)
Disease	Profound Mental Retardation	DOCK8 BDNF NRXN1 PHIP	4.87e-03	139	144	4	C0020796
Disease	Mental deficiency	DOCK8 BDNF NRXN1 PHIP	4.87e-03	139	144	4	C0917816
Disease	Mental Retardation, Psychosocial	DOCK8 BDNF NRXN1 PHIP	4.87e-03	139	144	4	C0025363

Protein segments in the cluster

Peptide	Gene	Start	Entry
LYELMTGQLPYSNIN	BRAF	646	P15056
SKPLLVQMDCNYNGY	ADAM5	51	Q6NVV9
KVYMGPGQLYQDLQN	ARHGEF10	741	O15013
YISNIGQYIMSLPLN	COG7	626	P83436
QLKQYFYETKCNPMG	BDNF	176	P23560
YLYNKPGDDIVLMAQ	BRDT	106	Q58F21
KKIYGSQPNFNMQYI	BMX	221	P51813
ISPAQVQGYFMLYKN	BCS1L	391	Q9Y276
QYNMDQFTPVKIEGY	CAPZA1	56	P52907
AQSQKGFTPLYMAAQ	ANK1	106	P16157
MKNASYNLDPYIQEF	AGO1	381	Q9UL18
ESYGQKMPEQVYIQL	DNAH11	1201	Q96DT5
ENEDIYYKSMPNLGA	ADGRL2	1401	O95490
YPLQMNLEYKFLSLN	ADAD1	461	Q96M93
QGMLSIGYAVYQVPK	CAPN8	426	A6NHC0
NAYIVSRQMSKYPSG	CFH	1056	P08603
SYYKQMLQAPTLVQG	DPY19L3	96	Q6ZPD9
EKDYNLQPMNAYGLF	ANO4	696	Q32M45
NMYKALLPQQSYSLA	BCOR	216	Q6W2J9
EMKSNYYSFIKQNNP	ASPM	456	Q8IZT6
NYGMQPTLYSVKEAL	AGBL1	661	Q96MI9
MQKAGIDPNAITYGY	DENND4A	836	Q7Z401
FLQYNSDNNMVKPLG	RAET1E	61	Q8TD07
IPYILKMETAEYNGQ	NR2C2	576	P49116
PIMYENFYSSQKNAV	PSTPIP2	281	Q9H939
VLNIFKNMNGSYSLP	PACRG	196	Q96M98
VAQMGNYQEYLKTLA	INTS6L	551	Q5JSJ4
SVPIAQMGNYQEYLK	INTS6	581	Q9UL03
MYPLDQSEYNNLKSA	GUF1	361	Q8N442
EYMLNNAVGSCQKPY	HIBCH	121	Q6NVY1
AQLIKPYMTQEGEYL	KCNJ4	221	P48050
NYRMKSYKNNALNPE	KPNA6	11	O60684
QLSGLYYNGLKVLNM	NRXN1	261	P58400
IDQISMKEAGYPNYL	MIS18BP1	441	Q6P0N0
YYLMQPSLQVSQGKL	LANCL1	226	O43813
LQHQAMKTPTNYYLF	NMUR2	71	Q9GZQ4
MNPGISKNSNYEPYN	MGAM2	406	Q2M2H8
LQAISKANPVNRYMY	MTMR6	221	Q9Y217
TGLQKFYMASNNLPV	LRRIQ4	211	A6NIV6
SPYYQELAGKSQLQM	IMPG1	256	Q17R60
LGSQAYSNKYLTMLQ	DST	5091	Q03001
YTLKCNYVDMGVQLP	KY	431	Q8NBH2
ISLNTNLYYGPNIMT	SMPDL3A	206	Q92484
NLYYGPNIMTLNKTD	SMPDL3A	211	Q92484
QCNASPQYLKEVSMY	CFAP65	856	Q6ZU64
PEDLYQKFMAYLSQG	HLCS	226	P50747
ELYVTNNCNLAYPMK	FSIP2	2781	Q5CZC0
NNVMSNYEAYKPSTG	DDX42	676	Q86XP3
GYNFDPKTYMRQTSQ	FAM135A	556	Q9P2D6
VPYEQLMNEYNKANS	KCNK5	481	O95279
IYMYLQPGNRASKDQ	OR2W1	256	Q9Y3N9
QCAMVKGYLTPNYLL	PGLYRP4	331	Q96LB8
ALQSPFYGDKMNLYS	NEK7	231	Q8TDX7
EFLQKLLPGYYMNLN	PIP5K1B	146	O14986
PFQNKYSHISMLDYN	OLFM1	441	Q99784
YNKCPYIIGTMNQGV	NAV3	2146	Q8IVL0
GLISPSDFAQLQKYM	DGKA	6	P23743
YDLISQFMQGYPSKV	MYOC	301	Q99972
YQLQPAMTQQIYDKF	PMF1	66	Q6P1K2
LPDKYQVMVNGQSSY	CLC	96	Q05315
QPPKQGMQYYLSSQD	MUL1	211	Q969V5
PILYYMLQKGGNSVT	NRIP1	1066	P48552
SEYTEKLQQYIAPGM	EPHB3	591	P54753
ADYYSQQMAQRVKLP	GBP6	331	Q6ZN66
NMYSLTDQKDLAPYL	GCN1	1641	Q92616
QLSGLYYNGLKVLNM	NRXN1	1266	Q9ULB1
VYYKQLGMSPSQSGL	MFSD6	91	Q6ZSS7
FPSMYLQKSGQDVSQ	NCF1B	276	A6NI72
FPSMYLQKSGQDVSQ	NCF1C	251	A8MVU1
SSPQMGQYGDTDYLK	PPT2	136	Q9UMR5
MQELENYSEGGPLYK	RGPD3	751	A6NKT7
VNYYVLNPKSITMGQ	DNAH1	1896	Q9P2D7
NPTTYQMDVNPEGKY	EGFR	271	P00533
QAAQKYEALYMGTLP	APBB3	286	O95704
YRMYQKGQETSTNPI	IDH1	316	O75874
PMTYLNKGQFYAITL	GRHL2	266	Q6ISB3
GLPLMIQIDTYSYNN	GRHL2	386	Q6ISB3
VLSSLPYKQYNMLNA	DOCK8	1276	Q8NF50
PYKQYNMLNADTTRN	DOCK8	1281	Q8NF50
TNMYNKDPAIVNGVY	CACNA2D3	176	Q8IZS8
QLALNATRKPMYYTG	FAM151A	311	Q8WW52
SNLELYQQYTAMAPK	C3orf20	6	Q8ND61
NNLMPGYEVAKYDLI	UGCG	126	Q16739
PTYQYNMNFEKLGKC	CASP7	56	P55210
PSQAFEYILYNKGIM	CTSH	186	P09668
SCQEPYYKMLNNNTG	MASP1	396	P48740
PSYSYKQSLNMAAVG	MCF2L	886	O15068
EYTQMYPGKDNRAIS	HBP1	451	O60381
GLYTISMNPANIYQF	DCAF8L1	336	A6NGE4
GMYLSVKGYNDKQPI	IDE	626	P14735
PDNKYIMSNSGDYEI	EML4	731	Q9HC35
KADAIYNMIGYPNFI	ECE1	496	P42892
YTNNGPLMDFISKNQ	HORMAD1	121	Q86X24
REYAQGMQKLASQYL	FCHSD2	51	O94868
IPGYQQASSSYKIQM	CFAP69	176	A5D8W1
IPSGYYLQTMNSNLN	SLC15A5	326	A6NIM6
MGSLYSEYLNPNKVQ	S1PR2	1	O95136
MKAVYQNISESNPAY	SLFN13	176	Q68D06
YQMDSKYPRNQALLG	IZUMO2	176	Q6UXV1
YDVSMYQSKDGKPLN	FOCAD	841	Q5VW36
TGYNLYNLQVKTEMD	OR5T3	6	Q8NGG3
PGNKNYTYMAQAVNR	NUP210L	1441	Q5VU65
QVRSLYYDMNKLDPQ	PTPRM	1166	P28827
YYDMNKLDPQTNSSQ	PTPRM	1171	P28827
NYINAALMDSYKQPS	PTPRM	1241	P28827
LNISNGNYYPIMVTQ	TMEM106A	146	Q96A25
QDHMLQYVLPGNKYL	USH2A	2201	O75445
NNYTLLNVTKVMYSG	USH2A	2376	O75445
YVNNKLYKTGMNVPG	USH2A	3056	O75445
LPGKQDVYLGVYLMN	SPATA6L	21	Q8N4H0
YQTPDLAMQLNQGKF	PLCB4	651	Q15147
NGVPSYMKSRLTYNQ	SKA1	146	Q96BD8
STYQSQKYQAEFPMG	LILRB1	371	Q8NHL6
GQPLNNYHMKTLVSY	MAB21L1	266	Q13394
YLNPNYKDATTMESI	SAMD9L	1346	Q8IVG5
EFLQKLLPGYYMNLN	PIP5K1C	196	O60331
MVQQKYFSNYSPVIG	PTCHD4	506	Q6ZW05
INGLMIKQLQYTAYG	TENM2	2381	Q9NT68
TIKKYVPNMNGYTEA	MYCBP2	2521	O75592
ITYYPAMKAVNEQGK	PTGES2	186	Q9H7Z7
ISFMPKYLEQQYGIS	SLCO1A2	336	P46721
MYIYSGNSLQDTKAP	PHAF1	171	Q9BSU1
KTPENYPNAGLTMNY	PLG	411	P00747
PNTVYQYGDMEVKQL	STMN3	31	Q9NZ72
TYYKMGNLDNRIANP	ABCD3	171	P28288
ENKCVYQSLYMGNEP	AKAP3	151	O75969
QSMYLEVQYAPKLQG	NCAM1	406	P13591
NNFLMTGPKAYLIYS	WNT8B	26	Q93098
YQYYLAQNIGLTGMK	ZFHX4	821	Q86UP3
SGYVNSMLQEYAKNP	CSE1L	406	P55060
EGNINSYYDRTMQKP	ZNF804B	1111	A4D1E1
KDQTCYNIIPLYNSM	PHIP	1261	Q8WWQ0
INYNNELPMYRKGTV	THG1L	226	Q9NWX6
FGMYVIYSKNKPQSD	PLEKHG4B	891	Q96PX9
KTSQTMELAPNFQGY	THEMIS2	66	Q5TEJ8
LLYTTPVQSGMYKLN	FGD6	1116	Q6ZV73
KLQNQPYYMQSSGVS	STAM	386	Q92783
SKYFPGQESQMKLIY	TMUB2	201	Q71RG4
GYKIEKDSRYSPQMQ	SLF1	91	Q9BQI6
AYMGKELPTNYNEAK	TAS1R2	746	Q8TE23
LGPSQKNLYRYVMQE	ZNF563	21	Q8TA94
VMLENYNNLITVGYP	ZNF569	36	Q5MCW4
YMTYGKTPFQQIINQ	TTK	726	P33981
QKSLMATSPAYRQQY	ZNF608	1091	Q9ULD9
DMQYPAQHKGQELYS	VPS13B	321	Q7Z7G8
YSNLLSMGYQVSKPD	ZNF432	41	O94892
KQVMADSGPIYDQTY	THBS2	1131	P35442
ATLYMLKNYPLNSES	VEZT	276	Q9HBM0
DSQMDVLLTYLPKNY	ITFG1	111	Q8TB96
PMNGYQKFSQELLSN	UBTF	571	P17480
LAVIPEGKIMNNTYY	ZFYVE26	2146	Q68DK2
MTEPQNSQGRYKGIY	ZNF285	156	Q96NJ3
DQGGEYVQPMLSKYA	TANGO2	211	Q6ICL3
PLFLSMQEGKNYTIY	TRAV39	26	A0A0B4J263
SMYGYDKKGNNANPE	LIPK	16	Q5VXJ0
RPIYDYLDNGNNKMA	NAA25	16	Q14CX7
YAANKNNMYSTPRVL	GRIN2A	1431	Q12879